1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed DyslipidemiaDyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, metabolic diseaseRecruitingPhase 22026-09-10NCT06797401